Medivir AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medivir AB with three other
miscellaneous service companies in Europe:
sales of 56.39 million Euro [US$61.89 million]
of which 101%
(77.54 million Euro [US$85.11 million]
of which 100%
was Nanobodies), and
based in Belgium
(60.58 million Euro [US$66.50 million]
of which 91%
Medivir AB reported sales of SEK 657.89 million (US$74.45 million)
December of 2015.
decrease of 62.8%
versus 2014, when the company's sales were SEK 1.77 billion.